Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lihou CF"'
Autor:
Lindley A; Incyte Corporation, Wilmington, DE, USA., Prager G; Medical University of Vienna, Department of Internal Medicine I, Comprehensive Cancer Center Vienna, Vienna, Austria., Bitzer M; Department of Internal Medicine I, Eberhard-Karls University, Tübingen, Germany., Burn TC; Incyte Corporation, Wilmington, DE, USA., Lihou CF; Incyte Corporation, Wilmington, DE, USA., Croft E; Incyte Corporation, Wilmington, DE, USA.
Publikováno v:
Cancer research and treatment [Cancer Res Treat] 2024 Jul; Vol. 56 (3), pp. 847-855. Date of Electronic Publication: 2024 Feb 07.
Autor:
Vogel A; Hannover Medical School, Hannover, Germany; Toronto General Hospital, Toronto; Princess Margaret Cancer Centre, Toronto, Canada. Electronic address: vogela@me.com., Sahai V; University of Michigan, Ann Arbor, USA., Hollebecque A; Gustave Roussy Cancer Center, Paris, France., Vaccaro GM; Providence Cancer Center, Portland, USA., Melisi D; Università degli studi di Verona, Verona, Italy., Al Rajabi RM; University of Kansas Medical Center, Kansas City., Paulson AS; Baylor University Medical Center, Dallas., Borad MJ; Mayo Clinic Cancer Center, Phoenix., Gallinson D; Morristown Memorial Hospital, Morristown., Murphy AG; Johns Hopkins University School of Medicine, Baltimore, USA., Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Republic of Korea., Dotan E; Fox Chase Cancer Center, Philadelphia., Catenacci DV; University of Chicago Medicine, Chicago, USA., Van Cutsem E; University Hospitals Gasthuisberg, Leuven & University of Leuven, Leuven, Belgium., Lihou CF; Incyte Corporation, Wilmington, USA., Zhen H; Incyte Corporation, Wilmington, USA., Veronese ML; Incyte International Biosciences Sàrl, Morges, Switzerland., Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York; Weill Medical College at Cornell University, New York, USA; Trinity College Dublin School of Medicine, Dublin, Ireland.
Publikováno v:
ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103488. Date of Electronic Publication: 2024 Jun 04.
Autor:
Subbiah V; Department of Investigational Cancer Therapeutics, The University of Texas, MD Anderson Cancer Center, Houston, USA. Electronic address: VSubbiah@mdanderson.org., Iannotti NO; Hematology Oncology Associates of the Treasure Coast, Stuart, USA., Gutierrez M; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, USA., Smith DC; University of Michigan Health System, Ann Arbor, USA., Féliz L; Incyte Biosciences International Sàrl, Morges, Switzerland., Lihou CF; Incyte Corporation, Wilmington, USA., Tian C; Incyte Corporation, Wilmington, USA., Silverman IM; Incyte Corporation, Wilmington, USA., Ji T; Incyte Corporation, Wilmington, USA., Saleh M; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, USA; Department of Hematology and Oncology, Aga Khan University, Nairobi, Kenya.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2022 May; Vol. 33 (5), pp. 522-533. Date of Electronic Publication: 2022 Feb 14.
Autor:
Bibeau K; Incyte Corporation, Wilmington, DE., Féliz L; Incyte Biosciences International Sàrl, Morges, Switzerland., Lihou CF; Incyte Corporation, Wilmington, DE., Ren H; Incyte Corporation, Wilmington, DE., Abou-Alfa GK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Medical College, Cornell University, New York, NY.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2022 Apr; Vol. 6, pp. e2100414.
Autor:
Bekaii-Saab TS; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Phoenix, AZ 85054, USA., Valle JW; Division of Cancer Sciences, University of Manchester & Department of Medical Oncology, The Christie Hospital NHS Foundation Trust, The University of Manchester, Manchester, UK., Van Cutsem E; Department of Oncology, University of Leuven, Leuven, Belgium., Rimassa L; Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Furuse J; Department of Medical Oncology, Kyorin University, Tokyo, Japan., Ioka T; Department of Cancer Survey and Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan., Melisi D; Department of Medicine, University of Verona, Verona, Italy., Macarulla T; Medical Oncology Department, Vall d'Hebron University Hospital & Vall d'Hebron Institute of Oncology, Barcelona, Spain., Bridgewater J; Research Department of Oncology, UCL Cancer Institute, University College London, London, UK., Wasan H; Department of Medical Oncology, Hammersmith Hospital, Imperial College Health Care Trust, London, UK., Borad MJ; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Phoenix, AZ 85054, USA., Abou-Alfa GK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Medical College, Cornell University, New York, NY, USA., Jiang P; Incyte Corporation, Wilmington, DE, USA., Lihou CF; Incyte Corporation, Wilmington, DE, USA., Zhen H; Incyte Corporation, Wilmington, DE, USA., Asatiani E; Incyte Biosciences International Sàrl, Morges, Switzerland., Féliz L; Incyte Biosciences International Sàrl, Morges, Switzerland., Vogel A; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2020 Oct; Vol. 16 (30), pp. 2385-2399. Date of Electronic Publication: 2020 Jul 17.
Autor:
Abou-Alfa GK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Medical College, Cornell University, New York, NY, USA. Electronic address: abou-alg@mskcc.org., Sahai V; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA., Hollebecque A; Gustave Roussy, Villejuif, France., Vaccaro G; Providence Cancer Center Oncology and Hematology Care Clinic, Portland, OR, USA., Melisi D; Digestive Molecular Clinical Oncology Unit, University of Verona, Verona, Italy., Al-Rajabi R; University of Kansas Cancer Center, Kansas City, KS, USA., Paulson AS; Baylor Charles A Sammons Cancer Center, Baylor University Medical Center, Dallas, TX, USA., Borad MJ; Mayo Clinic Cancer Center, Phoenix, AZ, USA., Gallinson D; Morristown Memorial Hospital, Carol Cancer Center, Morristown, NJ, USA., Murphy AG; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Oh DY; Cancer Research Institute, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea., Dotan E; Fox Chase Cancer Center, Philadelphia, PA, USA., Catenacci DV; University of Chicago Medicine, Chicago, IL, USA., Van Cutsem E; University Hospitals Gasthuisberg, Leuven, Belgium; Clinical Digestive Oncology, KU Leuven, Leuven, Belgium., Ji T; Incyte Corporation, Wilmington, DE, USA., Lihou CF; Incyte Corporation, Wilmington, DE, USA., Zhen H; Incyte Corporation, Wilmington, DE, USA., Féliz L; Incyte Corporation, Wilmington, DE, USA., Vogel A; Hannover Medical School, Hannover, Germany.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2020 May; Vol. 21 (5), pp. 671-684. Date of Electronic Publication: 2020 Mar 20.